Page not found

Search results

  1. Triple-negative breast cancer drug therapy shows promise

    ... breast cancer (TNBC), a particularly aggressive form of the disease, and identified a potential intervention for further ...

    sommers - 03/18/2020 - 11:40am

  2. Novel DNA repair mechanism preserves genome integrity: study

    ... and repair the abasic site. The ability of HMCES to form DNA-protein crosslinks might also make it an attractive drug target, similar to the topoisomerase enzymes that form such crosslinks and are targets for chemotherapy agents and antibiotics, ...

    sommers - 03/05/2019 - 9:56am

  3. Tech Connect: Vanderbilt-Ancora partnership advances research for Charcot-Marie-Tooth disease

    ... ring pattern, which may be familiar to our readers in the form of a coffee-ring stain. ...

    sommers - 11/30/2020 - 9:57am

  4. Project seeks new way to assess immunotherapy effectiveness

    ... allow researchers to manipulate radiopharmaceuticals in the form of small molecules paired with F-18 that focus on CD8+, among other ...

    sommers - 11/11/2019 - 1:40pm

  5. Rare study of Earth-sized planet uses technique pioneered by Vanderbilt professor

    ... Exoplanet Satellite Survey (TESS) mission. In its current form, the planet has little to no atmosphere and could be covered in the same ...

    sommers - 08/20/2019 - 8:32am

  6. 'Coffee Ring' Diagnostic for Point-of-Care Biomarker Detection

    ... ring pattern, which may be familiar to our readers in the form of a coffee-ring stain. Description of Technology How ...

    cttc_admin - 06/11/2019 - 3:04pm

  7. Correctly copying DNA - new research from Neil Osheroff

    ... enzyme topoisomerase II resolves topological roadblocks that form during the copying and expression of genetic material by generating ...

    sommers - 03/18/2019 - 2:12pm

  8. New Venture News: Prime time for entrepreneurs/inventors, network and learn

    ... venture or have an invention or new technology that could form a new venture. It will be held Wednesday, April 10, from 7:30 a.m. – ...

    cttc_admin - 02/21/2019 - 9:51am

  9. Boehringer Ingelheim, Vanderbilt team to develop new Ras inhibitors for cancer treatment

    ... known in cancer with K-Ras being the most commonly mutated form occurring in pancreas, colon, biliary tract and lung adenocarcinomas. ...

    nbmas - 02/21/2019 - 9:51am

  10. New Venture News: InvisionHeart named a finalist in Global Food and Health Innovation Challenge

    ... To learn more about the technology and how the group came to form, watch this short video featuring Baudenbacher and Eagle.  ...

    cttc_admin - 02/21/2019 - 9:51am